Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Clinical trial NCT02654054 · COMPLETED

Trial details

NCT number: NCT02654054
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uterine Fibroids Heavy Menstrual Bleeding

Start date: 2015-12-22
Primary completion: 2018-01-18
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.